Home

David Soergel

CIK 1591475 · Chief Medical Officer · last filed 2026-06-01

David Soergel is a Chief Medical Officer who has filed 14 SEC Form 4 insider transactions across 2 companies since 2014. The most recent filing, for MDGL, was dated Jun 1, 2026. Across all open-market trades the lifetime net is −$1.2M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $5.4M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$5.40M

Companies

2

Total Filings

14

Lifetime Open-Market Net

-$1.23M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
MDGL Chief Medical Officer 10,033 $538.71 $5.40M -$952.0K 4 2026-06-01
TREVENA INC (TRVN) Delisted Sr. VP,Clinical Dev. & CMO 3 $0.01 $0 -$275.2K 8 2017-03-03

Recent Filings

14 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-06-01 MDGL Notice (144) −1,042 -$518.2K EDGAR
2026-06-01 MDGL Sell (S) −1,042 -$516.6K EDGAR
2026-05-18 MDGL Sell (S) −844 -$435.4K EDGAR
2026-05-18 MDGL Notice (144) −844 -$442.0K EDGAR
2026-03-06 MDGL Grant (A) +4,374 $0 EDGAR
2025-05-16 MDGL Grant (A) +7,545 $0 EDGAR
2017-03-03 TREVENA INC (TRVN) Delisted Grant (A) — $0 EDGAR
2017-01-06 TREVENA INC (TRVN) Delisted Grant (A) — $0 EDGAR
2016-03-07 TREVENA INC (TRVN) Delisted Grant (A) — $0 EDGAR
2015-12-11 TREVENA INC (TRVN) Delisted Sell (S) −27,217 -$287.1K EDGAR
Showing 1–10 of 14
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.